Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
VOL 2 No. 4 Full Issue - April 2000
1
x
$
20.00
A Comprehensive Review of Solriamfetol to Treat Excessive Daytime Sleepiness
1
x
$
30.00
Asenapine in the Treatment of Bipolar Depression
1
x
$
30.00
Madhukar H. Trivedi - Research Evaluating the Value of Augmenting Medication with Psychotherapy:Rationale and Design
1
x
$
30.00
VOL 3 No. 3 Full Issue - March 2001
1
x
$
20.00
A Perspective on Adolescent Chronic Pain Dismissal
1
x
$
30.00
Pharmacy Practice: The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer: What Should Patients Be Told?
1
x
$
0.00
Diagnosis and Treatment of Depression in the Cancer Patient
1
x
$
0.00
Managing Deep Vein Thrombosis Risk in Oncology Patients Office and Outpatient Settings
1
x
$
10.00
Mikael Landén, MD, PhD: A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
1
x
$
30.00
Pharmacy Practice: The Contemporary Management of Colorectal Cancer
1
x
$
0.00
The Role of Irradiation in Endometrial Cancer
1
x
$
0.00
New Strategies for the Treatment of Indolent Non-Hodgkin’s Lymphomas
1
x
$
0.00
VOL 1 No. 1 Full Issue - May 1999
1
x
$
20.00
Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium
1
x
$
30.00
View Cart
Checkout
Home
Store
“Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Consecuencias psicosociales de la depresión adolescente
$
0.00
Add to cart
Details
Consequences of 1,4-Butanediol Misuse: A Review
$
30.00
Add to cart
Details
Consistently Modest Antidepressant Effects in Clinical Trials: the Role of Regulatory Requirements (OPEN ACCESS)
$
0.00
Add to cart
Details
Contemporary Management of Alzheimer’s Disease
$
30.00
Add to cart
Details
Continuous Positive Airways Pressure Treatment in a Patient with Sleep Apnea—Hypopnea Syndrome and Coexisting Bipolar Disorder
$
30.00
Add to cart
Details
Coping With Somatic Comorbidities: Striving for Complete Recovery
$
30.00
Add to cart
Details
Cornell Scale for Depression in Dementia
$
0.00
Add to cart
Details
Corrections to: Association Between Symptom Severity and Medication Adherence in Adolescents with Bipolar Disorder Demonstrating Suboptimal Adherence.
Details
Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses
$
30.00
Add to cart
Details
Craig H. Mallinckrodt, PhD: Simple Options for Improving Signal Detection in Antidepressant Clinical Trials
$
30.00
Add to cart
Details
Criteria for Defining Symptomatic and Sustained Remission in Bipolar I Disorder: a Post-Hoc Analysis of a 26-Week Aripiprazole Study (Study CN138-010)
$
30.00
Add to cart
Details
Critical Analysis of Recent Phase III Studies for the Treatment of Colorectal Cancer Implications for Future Clinical Trial Design
$
10.00
Add to cart
Details
Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
$
30.00
Add to cart
Details
DASS21
$
0.00
Add to cart
Details
David C. Steffens, MD, MHS: Cholesterol-Lowering Medication and Relapse of Depression
$
30.00
Add to cart
Details
David C. Steffens, MD, MHS: The Duke Somatic Treatment Algorithm for Geriatric Depression (STAGED) Approach
$
30.00
Add to cart
Details
David M. Lyons, PhD: Stress, Depression, and Inherited Variation in Primate Hippocampal and Prefrontal Brain Development
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
$
30.00
Add to cart
Details
David V. Sheehan, MD, MBA: The Speed of Onset of Action of Alprazolam-XR Compared to Alprazolam-CT in Panic Disorder
$
30.00
Add to cart
Details
David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder
$
30.00
Add to cart
Details
Previous
1
…
9
10
11
…
44
Next
Page load link
Go to Top
